Hearing outcome of sudden sensorineural hearing loss: Long-term follow-up

2008 ◽  
Vol 2008 ◽  
pp. 47-48
Author(s):  
B.J. Balough
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Sudden Sensorineural Hearing Loss ◽  
Sensorineural Hearing ◽  
Hearing Outcome ◽  
Long Term Follow Up

Hearing outcome of sudden sensorineural hearing loss: Long-term follow-up

2007 ◽  
Vol 136 (2) ◽  
pp. 221-224 ◽  
Author(s):  
Sang-Won Yeo ◽  
Dong-Hee Lee ◽  
Beom-Cho Jun ◽  
So-Young Park ◽  
Yong-Soo Park
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Sudden Sensorineural Hearing Loss ◽  
Sensorineural Hearing ◽  
Hearing Outcome ◽  
Long Term Follow Up

scholarly journals Long-term Follow-up Observation of Idiopathic Sudden Sensorineural Hearing Loss.

1994 ◽  
Vol 37 (4) ◽  
pp. 310-315
Author(s):  
Eiji Chida ◽  
Nobukiyo Satoh ◽  
Mitsugu Kawanami ◽  
Masaaki Kashiwamura ◽  
Satoshi Fukuda ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Sudden Sensorineural Hearing Loss ◽  
Sensorineural Hearing ◽  
Long Term Follow Up

Sudden Sensorineural Hearing Loss: Long-term Follow-up Results

2006 ◽  
Vol 134 (5) ◽  
pp. 809-815 ◽  
Author(s):  
Anestis D. Psifidis ◽  
George K. Psillas ◽  
Jiannis Ch. Daniilidis
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Sudden Sensorineural Hearing Loss ◽  
Sensorineural Hearing ◽  
Long Term Follow Up

scholarly journals Third-generation bisphosphonates for cochlear otosclerosis stabilizes sensorineural hearing loss in long-term follow-up

2017 ◽  
Vol 2 (5) ◽  
pp. 262-268 ◽  
Author(s):  
Taha A. Jan ◽  
Aaron K. Remenschneider ◽  
Christopher Halpin ◽  
Margaret Seton ◽  
Michael J. McKenna ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Sensorineural Hearing ◽  
Third Generation ◽  
Long Term Follow Up

scholarly journals The Short- and Long-Term Outcome of Intratympanic Steroid Therapy as a Salvage Treatment for Acute Low-Tone Sensorineural Hearing Loss without Episodes of Vertigo

2016 ◽  
Vol 21 (3) ◽  
pp. 132-140 ◽  
Author(s):  
Shinya Morita ◽  
Yuji Nakamaru ◽  
Keishi Fujiwara ◽  
Keiji Iizuka ◽  
Masayori Masuya ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Salvage Treatment ◽  
Sensorineural Hearing ◽  
Control Group ◽  
Long Term Follow Up ◽  
Low Tone ◽  
Hearing Outcomes

Objectives: To evaluate the hearing outcomes of intratympanic steroid (ITS) treatment for patients with acute low-tone sensorineural hearing loss (ALHL) after failure of initial therapy and to investigate the recurrence and progression to definite Ménière's disease (MD) during a long-term follow-up. Methods: We retrospectively reviewed the medical records of 90 patients with refractory ALHL who were followed up for at least 1 year between January 2000 and April 2014. Patients who responded poorly to initial medical treatment received intratympanic dexamethasone injections (ITS group) or isosorbide administration for 4 weeks (diuretic group) as salvage treatment options according to their choice of management. The control group did not receive ITS or the diuretic, due to their refusal of both medical treatments. The hearing outcomes were evaluated 1 month, 1 year and 5 years after the completion of the second-line therapy, and the rates of recurrence and progression to MD were measured during a follow-up period of at least 1 year. Results: Twenty-seven patients in the ITS group, 39 patients in the diuretic group and 24 patients in the control group were enrolled. Of these, 12 patients in the ITS group, 15 patients in the diuretic group and 12 patients in the control group were followed up for over 5 years. We found that the recovery rates and the audiometric functional values after 1 month and 1 year in the ITS group were significantly higher than those in the diuretic and control groups. However, there were no significant differences in the recovery rates or the audiometric functional values after 5 years, or in the rates of recurrence and progression to MD between the groups. Conclusions: Salvage ITS therapy can provide a relatively good short-term hearing outcome for ALHL patients who have persistent hearing loss despite conventional treatment. However, both recurrence and progression to MD after treatment were observed in some patients during the long-term follow-up.

scholarly journals A long-term follow-up study on sensorineural hearing loss associated with aortic arch syndrome.

1987 ◽  
Vol 80 (1) ◽  
pp. 43-48 ◽  
Author(s):  
Mikikazu Yamagiwa ◽  
Teruhiko Harada ◽  
Yasuo Sakakura ◽  
Chun Shun Jin
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Aortic Arch ◽  
Sensorineural Hearing ◽  
Follow Up Study ◽  
Aortic Arch Syndrome ◽  
Long Term Follow Up

Long-term follow up of sudden sensorineural hearing loss patients treated with intratympanic steroids: audiological and quality of life evaluation

2014 ◽  
Vol 128 (8) ◽  
pp. 669-673 ◽  
Author(s):  
I Dallan ◽  
S Fortunato ◽  
A P Casani ◽  
E Bernardini ◽  
S Sellari-Franceschini ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Sudden Sensorineural Hearing Loss ◽  
Sensorineural Hearing ◽  
Glasgow Benefit Inventory ◽  
Intratympanic Steroids

AbstractObjective:To evaluate the long-term stability of intratympanic steroids and investigate the ‘real’ impact of sudden sensorineural hearing loss on patients.Method:A total of 14 patients treated with intratympanic steroids were evaluated by audiometric and vestibular examinations. The modified Glasgow Benefit Inventory was used to evaluate quality of life changes after intratympanic steroid treatment.Results:There was no significant difference between pure tone average post-intratympanic steroids and at follow up. The general Glasgow Benefit Inventory score was not significantly associated with the presence of tinnitus or dizziness, or with patient age. The change in pure tone average after intratympanic steroid treatment did not correlate with social or physical scores, but correlated strongly with the general Glasgow Benefit Inventory score (p = 0.0023). Intratympanic steroid administration led to a stable improvement in hearing. Quality of life assessment showed that patients can feel satisfaction regardless of the hearing outcome. Patients who regained a social hearing level expressed greater satisfaction than patients without serviceable hearing. Overall, quality of life improvement was not related to hearing improvement.Conclusion:Sudden sensorineural hearing loss is devastating. Considering the audiological effects alone ignores the ‘human’ perspective. Audiological success can correlate with poor quality of life outcome.

scholarly journals Long-term Follow Up of Acute Low-tone Sensorineural Hearing Loss.

1994 ◽  
Vol 37 (2) ◽  
pp. 142-149 ◽  
Author(s):  
Masatoshi Hirayama ◽  
Tetsuya Shitara ◽  
Makito Okamoto ◽  
Hajime Sano
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Sensorineural Hearing ◽  
Long Term Follow Up ◽  
Low Tone
Sign in / Sign up

Export Citation Format

Share Document